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Objectives: During the period from December 2007 to November 2012, the epidemiology of 
diarrhea caused by Shigella was studied among children <5 years of age residing in Manhiça 
District, Southern Mozambique.
Materials and methods: Children from 0 to 5 years with moderate-to-severe diarrhea (MSD) 
and less severe diarrhea (LSD) were enrolled along with matched controls (by age, gender, and 
neighborhood). Age-stratified logistic regression analyses were conducted to identify clinical 
features and risk factors associated with Shigella positivity in cases of diarrhea. The impact of 
antibiotic treatment was assessed for patients with known outcome.
Results: A total of 916 cases of MSD and 1979 matched controls, and 431 cases of LSD with 
equal number of controls were enrolled. Shigella was identified as significant pathogen in both 
cases of MSD and LSD compared to their respective controls. Shigella was detected in 3.9% 
(17/431) of LSD compared to 0.5% (2/431) in controls (P=0.001) and in 6.1% (56/916) of 
MSD cases compared to 0.2% (4/1979) in controls (P<0.0001), with an attributable fraction of 
8.55% (95% CI: 7.86–9.24) among children aged 12–23 months. Clinical symptoms associated 
to Shigella among MSD cases included dysentery, fever, and rectal prolapse. Water availability, 
giving stored water to child, washing hands before preparing baby’s food, and mother as caretaker 
were the protective factors against acquiring diarrhea caused by Shigella. Antibiotic treatment 
on admission was associated with a positive children outcome.
Conclusion: Shigella remains a common pathogen associated with childhood diarrhea in 
Mozambique, with dysentery being a significant clinical feature of shigellosis. Adherence to 
the basic hygiene rules and the use of antibiotic treatment could contribute to the prevention of 
most of diarrhea due to Shigella.
Keywords: Shigella, moderate-to-severe diarrhea, less severe diarrhea, epidemiology
Introduction
Diarrhea is the leading cause of mortality in children <5 years with its long-term impact 
on growth and cognitive development.1 Although the burden is greater in low-income 
populations, acute infectious diarrhea is also a common cause of outpatient visits and 
hospital admissions in high-income regions and is an important health problem glob-
ally.2 Associated risk factors for infection include poor living standards, overcrowding, 
inadequate sanitation, and poor hand hygiene. These factors may result in a significant 
disease burden and economic effect due to direct medical costs, loss of work, lower 
quality of life, and mortality.3
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The high burden of the disease is also associated with the 
wide range of recognized enteric pathogens such as virus, 
bacteria, and parasites that may cause diarrhea.4 Among them, 
Shigella infections remain a global public health concern, in 
resource-limited countries where the disease may cause as many 
as 163 million episodes of diarrhea and over a million deaths 
annually with the majority (60%) occurring in children under 
5.5 Due to the high disease burden and endemicity of Shigella 
in resource-limited countries, the WHO has set the development 
of candidate vaccines against Shigella as priority.6 Thus, con-
sidering the efficacy of Shigella vaccine, it is necessary to have 
reliable estimates of the burden and epidemiology of disease in 
targeted endemic areas, including age-specific incidence data 
and risk factors associated with Shigella infections.
Primarily, shigellosis is transmitted from person to person 
through the fecal–oral route, but it may also spread indirectly 
by fecal contamination of water or food.7 Signs/symptoms 
of individuals who are infected with Shigella expand fever, 
painful bloody diarrhea, and stomach cramps.8 WHO recom-
mends that all episodes of diarrhea with blood in the stool 
must be treated with antibiotics.9 Antimicrobial therapies 
reduce the period and intensity of disease symptoms, decrease 
excretion of bacteria, and prevent potentially lethal compli-
cations. Decreasing the bacterial load excreted by a child 
with dysentery also reduces the probability of fecal–oral 
transmission to close contacts, such as neighbors, friends, 
or members of the child’s household.10
In Mozambique, epidemiologic data on diarrhea caused 
by Shigella remain scarce and existing data are limited to 
few studies.11,12 Moreover, the contribution of Shigella to 
less severe diarrhea (LSD), the risk factors, and the impact of 
antibiotic treatment on patient outcome remain unknown. We 
hereby report the epidemiology of diarrhea due to  Shigella 
among children <5 years of age enrolled between 2007 and 
2012 in Manhiça district as part of the Global Enteric Mul-
ticenter Study.13
Materials and methods
study area and population
The study was conducted by the Manhiça Health Research 
Centre (Centro de Investigação em Saúde de Manhiça – 
CISM) in Manhiça district, a rural area of Maputo province in 
southern Mozambique. The climate is subtropical with warm 
and rainy season from October to April and a fresh and dry 
season for the rest of the year. A round-the-clock morbidity 
surveillance system, covering pediatric inpatient and outpa-
tient visits, was established in 1998 in the Manhiça District 
Hospital in a joint collaboration with CISM. Clinical data are 
routinely collected from all children under 15 years seeking 
health care. HIV infection is among the highest worldwide, 
with prevalence rates in women in childbearing age as high 
as 40% in the district.14 Diarrhea is the third leading cause 
of hospital admission among children aged 0–14 years and 
the fourth cause of death in children from 12 to 59 months.15 
Additionally, since 1996, CISM has been running a Health 
Demographic Surveillance System (HDSS) for vital events 
and migrations in the population living within the study area 
covering approximately 95,000 inhabitants during the study 
period. In 2014, the study area was expanded to the whole 
district, and currently, 183,000 inhabitants are under DSS 
follow-up. Each person living within the DSS study area 
is issued a unique Permanent Identification Number that 
describes the geographic location, household number, and 
personal number within the household. A full description of 
the geographic and sociodemographic characteristics of the 
study community has been detailed elsewhere.16
study design
The present analysis is part of a prospective case–control 
study of diarrhea conducted in Manhiça district from Decem-
ber 2007 to November 2012 to estimate the burden and 
etiology of moderate-to-severe diarrhea (MSD) in children 
<5 years of age to guide future interventions. To assess the 
role of Shigella in LSD, cases of LSD were enrolled from 
November 3rd 2011 to November 2nd 2012. Age in months 
was stratified in three strata (0–11, 12–23, and 24–59). 
Clinical and epidemiologic data were collected over the 
study period. Cases of diarrhea included in the study corre-
sponded to children <5 years of age living within the HDSS 
area presenting to Manhiça district hospital with symptoms 
of diarrhea, defined as three or more loose stools in the last 
24 hours. Clinicians assessed each child with diarrhea for 
eligibility; to be included, the episode had to be new (onset 
after ≥7 diarrhea-free days), acute (onset within the previ-
ous 7 days), and fulfill at least one of the following criteria 
for MSD: sunken eyes (confirmed by parent or caretaker 
as more than normal); loss of skin turgor (abdominal skin 
pinch with slow [≤2 seconds] or very slow [≥2 seconds] 
recoil); intravenous hydration administered or prescribed; 
dysentery (visible blood in loose stools); or admission to 
hospital with diarrhea or dysentery.17 For each child with 
diarrhea, one to three healthy control children (no story of 
diarrhea in the previous 7 days, matched by age, sex, and 
neighborhood) were randomly selected using the HDSS 
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Shigella-diarrhea in Mozambican children
sample collection and laboratory analysis
Fecal samples from cases were collected within 12 hours of 
registration of the diarrheal episode, and control samples 
within 14 days after case enrolment. Once collected, samples 
were kept in a cool box until processed. Each fecal speci-
men comprised a whole stool specimen (in screw top fecal 
specimen cups carried in Styrofoam boxes with cold packs), 
a fecal swab in Modified Cary Blair medium in a plastic 
screw top test tube, and a fecal swab in buffered glycerol 
saline in a screw top test tube.13 Additionally, if antibiotics 
were to be given to patients before the production of stool 
sample, two rectal swabs were obtained for bacterial culture 
pending passage of the whole stool for the remaining assays. 
Stool samples were tested for the presence of bacterial, viral, 
and parasitic pathogens by culture, ELISA, and PCR as 
appropriate.18 In the case of Shigella, species were identified 
by colonies morphology upon culturing in MacConkey and 
XLD followed by slide agglutination with specific antisera 
(Denka Seiken Co., Ltd., Tokyo, Japan).
Data analysis
The software for analysis was Stata/SE version 14.1 (STATA 
Corporation, College Station, TX, USA) and the package 
coxphf from R version 3.2.2. All analyses were stratified by 
age. The frequency of Shigella isolation was calculated divid-
ing the number of Shigella positivity by the total number of 
children enrolled over the study period with known culture 
result for Shigella. The pathogenicity of Shigella was assessed 
comparing the isolation rate between cases of diarrhea and 
control group. Logistic regression models were used to evalu-
ate associations. All models were estimated with the penalized 
likelihood according to the Firth’s approach.19,20 Multivariable 
models were estimated by forward-stepwise selection from 
covariates with a P-value<0.20 in the crude models and no 
more than 5% of missing values. Significant levels for removal 
and addition in the multivariable models were 0.10 and 0.05, 
respectively, by Wald test. The association between MSD and 
Shigella was assessed at crude level for all pathogens and for 
Shigella adjusted for other significant pathogens and pairwise 
interactions between each one of them with Shigella. Analysis 
of sign/symptoms and sociodemographic factors associated 
with Shigella-MSD vs other types of MSD was performed 
among MSD cases. Interactions between significant covariates 
in the multivariable model were also assessed.
Ethical approval
The study is part of the Global Enteric Multi-Center Study 
(GEMS), which was approved by the Institutional Review 
Board at the University of Maryland School of Medicine, 
USA and the National Bioethics Committee for Health of 
Mozambique and Hospital Clinic, University of Barcelona, 
Spain. A written informed consent was obtained from chil-
dren’s mothers or caretakers for participation in the study.
Results
Shigella and association with diarrhea
During the study period, a total of 916 cases and 1979 con-
trols for MSD (December 9, 2007 to November 2, 2012), and 
431 LSD cases and their respective 431 matched controls 
(November 3, 2011 to November 2, 2012) were enrolled. 
Shigella was isolated in 6.1% (56/916) of MSD cases com-
pared to 0.2% (4/1979) in controls (P<0.0001) and in 3.9% 
(17/431) of LSD compared to 0.5% (2/431) in control group 
(Table 1). In addition, Shigella infection was predominantly 
detected during rainy season (October–March) compared to 
dry season (Figure 1). The incidence rate of Shigella-associ-
ated MSD was 0.61 per 100 child-year (95% CI: 0.48–0.74) 
with an attributable fraction of 8.55 (95% CI: 7.86–9.24) in 
children aged 12–23 months. A strong association of Shigella 
and MSD was found by both crude and pathogen-adjusted 
multivariate analysis for all age groups especially in children 
aged 24–59 months where adjusted odds ratio (aOR) of 
190.92 (95% CI: 23.80–24565.84; P<0.0001) was observed 
as shown in Table 2.
clinical presentation
The clinical characteristics (signs and symptoms) of chil-
dren infected with Shigella were compared with non-MSD 
 Shigella using crude and multivariate analysis and presented 
in Table 3. The odds of having Shigella infections were 
Table 1 Detection rate of Shigella among children 0–59 months 
of age with diarrhea (MsD and lsD) and their matched controls 
in Manhiça district, December 2007 to november 2012
Age groups Case/control P-value
Controls, n (%) Cases, n (%)
MsD
0–11 months 1/1047 (0.1) 6/495 (1.2) 0.002
12–23 months 2/629 (0.3) 21/276 (7.6) <0.0001
24–59 months 1/303(0.3) 29/145 (20) <0.0001
Total 4/1979 (0.2) 56/916 (6.1) <0.0001
lsD
0–11 months 0/155 (0) 1/155 (0.7) 0.317
12–23 months 1/175 (0.6) 10/175 (5.7) 0.006
24–59 months 1/101 (1) 6/101 (5.9) 0.054
Total 2/431 (0.5) 17/431 (3.9) 0.001
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Table 2 crude and pathogen-adjusted multivariate analysis of the association of Shigella spp. with moderate-to-severe diarrhea among 
children under 5 years (December 2007–november 2012)
Variables Group Crude analysis Adjusted analysis
Controls, n (%) Cases, n (%) OR (95% CI) P-value Adjusted OR (95% CI) P-value
0–11 months
Shigella spp. 1/1047 (0) 6/495 (1) 22.01 (2.44–2912.20) 0.0028 42 (93.96–5717.57) 0.0008
cryptosporidium 96/1046 (9) 98/495 (20) 2.89 (2.07–4.06) <0.0001 3.71 (2.54–5.50) <0.0001
giardia 177/1046 (17) 45/495 (9) 0.48 (0.33–0.68) <0.0001 0.47 (0.31–0.69) 0.0001
Rotavirus 160/1046 (15) 217/495 (44) 5.91 (4.42–8.01) <0.0001 6.37 (4.69–8.79) <0.0001
adenovírus (40/41) 9/1044 (1) 12/493 (2) 3.05 (1.25–7.75) 0.0144 4.43 (1.62–12.57) 0.0038
nontyphoidal Salmonella 6/1047 (1) 6/495 (1) 2.53 (0.81–7.85) 0.108
Campylobacter 52/1047 (5) 30/495 (6) 1.45 (0.88–2.38) 0.1456
sapovírus 29/1047 (3) 9/495 (2) 0.61 (0.26–1.28) 0.1967
enteroaggregative E. coli 
(aaic only)
59/1047 (6) 40/495 (8) 1.38 (0.89–2.12) 0.1527
12–23 months
Shigella spp. 2/629 (0) 21/276 (8) 20.75 (6.61–103.57) <0.0001 20.6 (6.30–105.59) <0.0001
cryptosporidium 60/628 (10) 51/275 (19) 2.63 (1.70–4.08) <0.0001 2.61 (1.62–4.23) <0.0001
giardia 278/628 (44) 74/275 (27) 0.44 (0.32–0.61) <0.0001 045 (0.32–0.63) <0.0001
Rotavirus 102/628 (16) 62/275 (23) 1.87 (1.28–2.75) 0.0014 2.07 (1.36–3.16) 0.0007
eaec (aatA only) 30/629 (5) 30/276 (11) 2.14 (1.22–3.80) 0.0079 2.12 (1.15–3.96) 0.0168
Aeromonas spp. 2/629 (0) 3/276 (1) 4.20 (0.82–25.21) 0.0837
Vibrio cholerae 01 1/629 (0) 4/276 (1) 3.97 (0.69–41.39) 0.1255
nontyphoidal Salmonella 0/629 (0) 2/276 (1) 15.00 (1.22–2068.84) 0.0336
adenovírus (40/41) 12/628 (2) 4/272 (1) 1.08 (0.33–2.97) 0.1416
24–59 months
Shigella spp. 1/303 (0) 29/145 (20) 126.56 (17.67–16063.77) <0.0001 191 (23.80–24565.84) <0.0001
giardia 155/303 (51) 50/145 (34) 0.51 (0.32–0.78) 0.0022 0.43 (0.25–0.72) 0.001
eaec (aatA/aaic) 10/303 (3) 1/145 (1) 0.25 (0.03–1.13) 0.0743 0.07 (0.00–0.81) 0.0284
V. cholerae 0/303 (0) 9/145 (6) 23.41 (2.87–3044.31) 0.0008 19.6 (2.48–2523.83) 0.0015
cryptosporidium 22/303 (7) 11/145 (8) 1.35 (0.60–2.94) 0.4577
norovírus 15/303 (5) 5/145 (3) 0.46 (0.16–1.18) 0.1091
adenovírus (non-40/41) 8/303 (3) 0/145 (0) 0.11 (0.00–1.01) 0.0519
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Shigella-diarrhea in Mozambican children
Table 3 clinical presentation of Shigella-associated MsD by crude and pathogen-adjusted analysis





OR (95% CI) P-value Adjusted OR  
(95% CI)
P-value
0–11 months of age
Dysentery 35/489 (7) 1/6 (17) 3.49 (0.56–21.93) 0.1823
sunken eyes 279/489 (57) 3/6 (50) 0.75 (0.17–3.35) 0.7096
loss of skin turgor 172/489 (35) 2/6 (33) 1.02 (0.22–4.85) 0.9776
Intravenous rehydration 259/489 (53) 3/6 (50) 0.89 (0.20–3.95) 0.8763
hospitalized 344/489 (70) 5/6 (83) 1.55 (0.25–9.52) 0.6369
Vomiting 3 or more times per daya 266/489 (54) 2/6 (33) 0.47 (0.10–2.21) 0.3361
Very thirstya 345/487 (71) 4/6 (67) 0.74 (0.16–3.53) 0.7079
Drank much less than usuala 70/489 (14) 1/6 (17) 1.62 (0.26–10.05) 0.6027
Unable to drinka 43/489 (9) 0/6 (0) 0.79 (0.04–14.25) 0.8728
Belly paina 129/489 (26) 2/6 (33) 1.55 (0.33–7.35) 0.5836
Fevera 170/489 (35) 2/6 (33) 1.04 (0.22–4.94) 0.9596
Irritability or restless attitudea 82/488 (17) 3/6 (50) 4.93 (1.10–22.09) 0.0372
Decreased activity or lethargya 238/488 (49) 1/6 (17) 0.29 (0.05–1.76) 0.1768
loss of consciousnessa 8/489 (2) 0/6 (0) 4.36 (0.23–83.70) 0.3290
Rectal straininga 24/489 (5) 0/6 (0) 1.46 (0.08–26.70) 0.7979
Rectal prolapsea 2/489 (0) 0/5 (0) 17.73 (0.76–413.90) 0.0737
cougha 331/489 (68) 3/6 (50) 0.48 (0.11–2.13) 0.3329
Difficulty breathinga 54/489 (11) 1/6 (17) 2.18 (0.35–13.55) 0.4034
convulsiona 13/489 (3) 0/6 (0) 2.72 (0.15–50.69) 0.5036
Very thirstyb 349/487 (72) 4/6 (67) 0.71 (0.15–3.39) 0.6709
Drinks poorlyb 60/488 (12) 1/6 (17) 1.93 (0.31–11.99) 0.4796
sunken eyesb 268/488 (55) 3/6 (50) 0.82 (0.18–3.65) 0.7959
Wrinkled skinb 165/488 (34) 1/6 (17) 0.53 (0.09–3.27) 0.4970
Irritable or restlessb 78/489 (16) 2/6 (33) 2.91 (0.61–13.93) 0.1806
lethargy or loss of consciousnessb 238/489 (49) 1/6 (17) 0.29 (0.05–1.76) 0.1782
Dry mouthb 216/488 (44) 1/6 (17) 0.34 (0.06–2.11) 0.2480
Fast breathingb 148/489 (30) 1/6 (17) 0.63 (0.10–3.85) 0.6145
Undernutrition 48/489 (10) 0/6 (0) 0.70 (0.04–12.62) 0.8092
low or very low skin pinch 144/450 (32) 1/5 (20) 0.71 (0.11–4.53) 0.7147
12–23 months of age
Dysentery 45/255 (18) 9/21 (43) 3.52 (1.43–8.67) 0.0063 3.99 (1.53–10.39) 0.0046
sunken eyes 121/255 (47) 6/21 (29) 0.46 (0.18–1.20) 0.1127
loss of skin turgor 66/255 (26) 4/21 (19) 0.73 (0.25–2.14) 0.5700
Intravenous rehydration 113/255 (44) 7/21 (33) 0.65 (0.26–1.62) 0.3553
hospitalized 172/255 (67) 12/21 (57) 0.64 (0.26–1.54) 0.3168
Vomiting 3 or more times per daya 124/255 (49) 7/21 (33) 0.55 (0.22–1.36) 0.1953
Very thirstya 208/255 (82) 15/20 (75) 0.64 (0.23–1.79) 0.3957
Drank much less than usuala 14/255 (5) 1/21 (5) 1.22 (0.21–6.95) 0.8238
Unable to drinka 16/255 (6) 1/21 (5) 1.06 (0.19–6.00) 0.9456
Belly paina 68/255 (27) 6/21 (29) 1.15 (0.44–2.99) 0.7776
Fevera 84/255 (33) 10/21 (48) 1.85 (0.77–4.45) 0.1676 3.02 (1.15–7.94) 0.025
Irritability or restless attitudea 40/255 (16) 1/21 (5) 0.39 (0.07–2.11) 0.2744
Decreased activity or lethargya 135/255 (53) 9/21 (43) 0.68 (0.28–1.63) 0.3821
loss of consciousnessa 5/255 (2) 0/21 (0) 1.06 (0.06–19.80) 0.9693
Rectal straininga 12/254 (5) 1/21 (5) 1.42 (0.25–8.19) 0.6952
Rectal prolapsea 0/255 (0) 0/21 (0) – –
cougha 159/255 (62) 7/21 (33) 0.31 (0.13–0.78) 0.0130 0.27 (0.10–0.72) 0.0085
Difficulty breathinga 21/255 (8) 0/21 (0) 0.25 (0.01–4.33) 0.3435
convulsiona 12/255 (5) 1/21 (5) 1.43 (0.25–8.22) 0.6918
Very thirstyb 209/255 (82) 15/21 (71) 0.53 (0.20–1.40) 0.1983
Drinks poorlyb 15/254 (6) 1/21 (5) 1.13 (0.20–6.41) 0.8897
sunken eyesb 124/255 (49) 6/21 (29) 0.44 (0.17–1.14) 0.0923
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 associated with significant clinical features according to 
age, and the results from adjusted analysis are highlighted 
here. Dysentery, a classic symptom of shigellosis, was one 
of the most important features of diarrhea caused by Shi-
gella compared to non-Shigella-MSD in both children aged 
12–23 months (aOR =3.99; 95% CI: 153–10.39; P=0.0046) 
and 24–59 months (aOR =5.29; 95% CI: 2.05–13.66; 
P=0.0006). Moreover, the proportion of Shigella isolation 
was high among bloody diarrheal cases (20.1%; 32/158) 
compared to only 3.2% (24/758) for watery diarrhea, with 
the highest rate in children aged 24–59 months  accounting 





OR (95% CI) P-value Adjusted OR  
(95% CI)
P-value
Irritable or restlessb 41/255 (16) 2/21 (10) 0.66 (0.17–2.58) 0.5526
lethargy or loss of consciousnessb 125/253 (49) 9/21 (43) 0.78 (0.32–1.87) 0.5759
Dry mouthb 112/255 (44) 8/21 (38) 0.80 (0.33–1.96) 0.6304
Fast breathingb 53/253 (21) 2/21 (10) 0.48 (0.12–1.85) 0.2875
Undernutrition 69/255 (27) 4/21 (19) 0.69 (0.24–2.02) 0.4975
low or very low skin pinch 50/237 (21) 4/19 (21) 1.08 (0.36–3.22) 0.8931
24–59 months of age
Dysentery 46/116 (40) 22/29 (76) 4.55 (1.84–11.25) 0.0010 5.29 (2.05–13.66) 0.0006
sunken eyes 43/116 (37) 8/29 (28) 0.67 (0.28–1.61) 0.3679
loss of skin turgor 20/116 (17) 2/29 (7) 0.43 (0.11–1.70) 0.2279
Intravenous rehydration 34/116 (29) 5/29 (17) 0.54 (0.20–1.47) 0.2258
hospitalized 59/116 (51) 5/29 (17) 0.22 (0.08–0.59) 0.0026
Vomiting 3 or more times per daya 38/116 (33) 3/29 (10) 0.27 (0.08–0.88) 0.0293
Very thirstya 93/116 (80) 22/29 (76) 0.75 (0.29–1.93) 0.5569
Drank much less than usuala 11/116 (9) 1/29 (3) 0.48 (0.08–2.78) 0.4151
Unable to drinka 9/116 (8) 3/29 (10) 1.49 (0.41–5.47) 0.5438
Belly paina 23/116 (20) 10/29 (34) 2.14 (0.89–5.14) 0.0883
Fevera 40/115 (35) 11/29 (38) 1.16 (0.51–2.66) 0.7275
Irritable or restlessa 9/115 (8) 2/29 (7) 1.02 (0.24–4.37) 0.9796
Decreased activity or lethargya 58/115 (50) 10/29 (34) 0.53 (0.23–1.22) 0.1348
loss of consciousnessa 2/116 (2) 1/29 (3) 2.41 (0.31–19.02) 0.4038
Rectal straininga 9/115 (8) 5/29 (17) 2.52 (0.81–7.86) 0.1120
Rectal prolapsea 0/116 (0) 1/29 (3) 12.26 (0.49–308.99) 0.1279 32.08 (1.18–869.71) 0.0394
cougha 52/116 (45) 13/29 (45) 1.01 (0.45–2.25) 0.9900
Difficulty breathinga 2/115 (2) 0/29 (0) 0.77 (0.04–16.46) 0.8669
convulsiona 8/116 (7) 1/29 (3) 0.67 (0.11–4.00) 0.6621
Very thirstyb 94/116 (81) 22/29 (76) 0.71 (0.28–1.84) 0.4856
Drinks poorlyb 15/116 (13) 1/29 (3) 0.34 (0.06–1.94) 0.2266
sunken eyesb 45/116 (39) 8/29 (28) 0.62 (0.26–1.49) 0.2873
Wrinkled skinb 19/116 (16) 2/29 (7) 0.45 (0.11–1.81) 0.2638
Irritability or restless attitudeb 3/116 (3) 2/29 (7) 2.95 (0.55–15.75) 0.2060
lethargy or loss of consciousnessb 52/116 (45) 9/29 (31) 0.57 (0.24–1.33) 0.1946
Dry mouthb 35/116 (30) 5/29 (17) 0.52 (0.19–1.41) 0.1962
Fast breathingb 8/116 (7) 0/29 (0) 0.22 (0.01–3.86) 0.2977
Undernutrition 8/116 (7) 0/29 (0) 0.22 (0.01–3.86) 0.2977
low or very low skin pinch 16/108 (15) 1/28 (4) 0.31 (0.05–1.72) 0.1782
Notes: asince began; bcurrent.
Abbreviation: MsD, moderate-to-severe diarrhea.
Table 3 (Continued)
with  approximately one-third of all bloody diarrheal cases 
(Table 4). Fever was also an important symptom of Shi-
gella-MSD in children from 12 to 23 months (aOR =3.02; 
1.15–7.94; P=0.025) while rectal prolapse in 24–59 months 
(aOR =32.08; 1.18–869.71; P=0.0394). Irritability or restless 
attitude was an important sign for infants by crude analysis 
(OR =4.93; 1.10–22.9; P=0.0372).
Risk factors
The role of different risk factors for MSD was age-dependent, 
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explanatory variables were not statistically significant 
(Table 5). Partial or exclusive breastfeeding was a remark-
able protective factor against Shigella in younger children 
aged 0–11 months with MSD by crude analysis (OR =0.10; 
0.02–0.68; P=0.0184). Protective factors in children aged 
12–23 months included partial or exclusive breastfeeding 
(OR =0.12; 0.04–0.40; P=0.0006), mother as primary child 
caretaker (aOR =0.28; 0.09–0.87; P=0.0281), and giving 
stored water to child (aOR =0.17; 0.04–0.82; P=0.0267). In 
24–59 months, water availability (not always per day) (aOR 
=0.32; 0.12–0.81; P=0.0167) and washing hands before 
preparing baby’s food (aOR =0.28; 0.08–0.94; P=0.0394) 
were protective against shigellosis. Among controls (Table 6), 
relevant protective factors for acquiring Shigella included 
child primary caretaker for children aged 0–11 months (aOR 
=0.03; 0.00–0.87; P=0.0408), and washing hands before 
eating in children aged 12–23 months (aOR =0.05; 0.01, 
0.52; P=0.0119).
Impact of antibiotic treatment on patient 
outcome
The impact of antibiotic treatment on patient outcome was 
assessed among children with known outcome (Table 7). 
Patient outcome was available for all of Shigella-diarrheal 
children while antibiotic treatment was administered in 
only 30.1% (22/73). The most administered antibiotics 
were ampicillin and gentamicin (12.3%; 9/73), followed by 
trimethoprim-sulfametoxazole (9.6%; 7/73), chlorampheni-
col (8.2%; 6/73), and nalidixic acid (6.9%; 5/73). Although 
high rates of resistance were found, patient improvement at 
discharge was much higher in children that received antibiotic 
treatment (63.0%; 17/27) compared to 37.0% (10/27), for 
those without any treatment (P<0.0001).
Discussion
In this prospective, case–control study, we demonstrated the 
association of Shigella spp. with MSD and LSD among chil-
dren under 5 years in Manhiça District, a rural area of south-
ern Mozambique. Its low detection rate in children without 
diarrhea and in cases of LSD confirms the high probability 
that whenever present, this pathogen causes a virulent disease, 
which could be explained in part by the low infectious dose of 
the bacterium (10–100 cells).21 While an association between 
Enterobacteriaceae and Giardia has been reported,22 in this 
study we showed that the prevalence of Giardia was indepen-
dent of Shigella by adjusted analysis. In addition, Giardia was 
more common in controls while Shigella was mostly isolated 
in cases. The proportion of cases presenting with Shigella 
was similar with those reported in our previous study12 and 
in other African countries.3,23,24 Overall, the detection rate of 
Shigella was high during rainy season, which is similar to 
other studies.25 As expected, the classical signs/symptoms of 
Shigella-MSD were mostly of dysentery accompanied with 
fever or rectal prolapse.8 Irritability or restless attitude was 
also an importance feature in infants. The observation that 
Shigella may also be associated with less severe cases is a 
matter of concern, because the disease is mostly considered 
severe and frequently associated with dysentery. These find-
ings expand the spectrum of clinical features associated with 
Shigella infection and demonstrate the importance of active 
surveillance for disease prevention. Another explanation 
could be related to health-seeking behavior, meaning that 
mothers or child caretakers are looking for assistance earlier 
before the disease becomes severe, as demonstrated in our 
community study about health care utilization and attitudes 
in cases of MSD.26
The finding that children who received antibiotic treat-
ment was associated with a good outcome at the discharge, 
reinforcing the importance of antibiotic therapy for the man-
agement of shigellosis. Similar reports have shown that, with 
an effective antibiotic therapy, clinical improvement occurs 
within 48 hours,27 resulting in a decreased risk of serious 
complications and death, shorter duration of symptoms, the 
elimination of Shigella from the stool, and subsequently 
decreased infection transmission.
MSD caused by Shigella was associated with a high OR 
compared to other significant pathogens in adjusted analysis, 
which may suggest its high pathogenicity as observed by 
the low detection rate in healthy children compared to other 
significant pathogens. In accordance with previous reports,28 
Table 4 crude analysis of Shigella-associated diarrhea by severity (bloody diarrhea and watery diarrhea) in the different age groups 
(December 2007–november 2012)
Age groups Watery diarrhea, n (%) Bloody diarrhea, n (%) OR (95% CI) P-value
0–11 months 5/459 (1) 1/36 (3) 3.49 (0.56–21.93) 0.1823
12–23 months 12/222 (5) 9/54 (17) 3.52 (1.43–8.67) 0.0063
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Table 5 Risk factors of Shigella-associated moderate-to-severe diarrhea by crude and adjusted analysis









>6 months of age 259/489 (53) 5/6 (83) 3.26 (0.53–19.98) 0.2021
child sex (male) 294/489 (60) 4/6 (67) 1.19 (0.25–5.67) 0.8226
child primary caretaker (mother) 473/489 (97) 6/6 (100) 0.45 (0.02–8.38) 0.5948
caretaker formal education 135/487 (28) 3/6 (50) 2.60 (0.58–11.60) 0.2100
animals in compound 411/489 (84) 4/6 (67) 0.34 (0.07–1.64) 0.1806
Water availability (not always per day) 256/488 (52) 4/6 (67) 1.63 (0.34–7.73) 0.5375
access to improved water 411/489 (84) 4/6 (67) 0.34 (0.07–1.64) 0.1806
give stored water to child 450/489 (92) 6/6 (100) 1.14 (0.06–20.61) 0.9294
Treating water habit 54/489 (11) 1/6 (17) 2.18 (0.35–13.55) 0.4034
Facility to dispose child’s stool 248/486 (51) 2/6 (33) 0.53 (0.11–2.53) 0.4284
Improved facility for household stool 43/488 (9) 0/6 (0) 0.79 (0.04–14.22) 0.8716
Wash hands before eating 463/489 (95) 5/6 (83) 0.21 (0.03–1.33) 0.0974
Wash hands before cooking 304/489 (62) 3/6 (50) 0.61 (0.14–2.71) 0.5152
Wash hands before preparing baby’s food 129/489 (26) 3/6 (50) 2.78 (0.62–12.42) 0.1796
Wash hands after defecating 413/489 (84) 6/6 (100) 2.41 (0.13–43.14) 0.5513
Wash hands after handling animals 12/489 (2) 0/6 (0) 2.94 (0.16–55.07) 0.4710
Wash hands after cleaning child feces 127/489 (26) 2/6 (33) 1.58 (0.33–7.51) 0.5655
Partial or exclusive breastfeeding 413/424 (97) 5/6 (83) 0.10 (0.02–0.68) 0.0184
lowest quintile of wealth index 110/484 (23) 2/6 (33) 1.88 (0.40–8.96) 0.4268
12–23 months
>18 months of age 75/255 (29) 10/21 (48) 2.18 (0.91–5.26) 0.0816
child sex (male) 147/255 (58) 10/21 (48) 0.67 (0.28–1.61) 0.3713
child primary caretaker (mother) 237/255 (93) 17/21 (81) 0.30 (0.10–0.95) 0.0398 0.28 (0.09–0.87) 0.0281
caretaker formal education 58/253 (23) 4/21 (19) 0.86 (0.29–2.52) 0.7825
animals in compound 213/255 (84) 16/21 (76) 0.60 (0.22–1.66) 0.3217
Water availability (not always per day) 140/255 (55) 11/21 (52) 0.90 (0.38–2.15) 0.8135
access to improved water 214/255 (84) 16/21 (76) 0.58 (0.21–1.61) 0.2962
give stored water to child 249/255 (98) 19/21 (90) 0.20 (0.04–0.94) 0.0412 0.17 (0.04–0.82) 0.0267
Treating water habit 14/255 (5) 2/21 (10) 2.14 (0.52–8.83) 0.2948
Facility to dispose child’s stool 207/253 (82) 18/21 (86) 1.18 (0.36–3.88) 0.7796
Improved facility for household stool 15/255 (6) 0/21 (0) 0.36 (0.02–6.24) 0.4834
Wash hands before eating 225/255 (88) 19/21 (90) 1.05 (0.27–4.15) 0.9390
Wash hands before cooking 152/255 (60) 11/21 (52) 0.74 (0.31–1.78) 0.5055
Wash hands before preparing baby’s food 78/255 (31) 4/21 (19) 0.58 (0.20–1.69) 0.3203
Wash hands after defecating 219/255 (86) 19/21 (90) 1.30 (0.33–5.07) 0.7083
Wash hands after handling animals 4/255 (2) 0/21 (0) 1.30 (0.07–24.95) 0.8619
Wash hands after cleaning child feces 59/255 (23) 7/21 (33) 1.71 (0.68–4.32) 0.2581
Partial or exclusive breastfeeding 139/214 (65) 3/18 (17) 0.12 (0.04–0.40) 0.0006
lowest quintile of wealth index 55/255 (22) 2/21 (10) 0.46 (0.12–1.79) 0.2637
24–59 months
>42 months of age 25/116 (22) 3/29 (10) 0.47 (0.14–1.57) 0.2218
child sex (male) 68/116 (59) 19/29 (66) 1.31 (0.57–3.03) 0.5208
child primary caretaker (mother) 100/116 (86) 28/29 (97) 3.12 (0.56–17.46) 0.1955
caretaker formal education 23/115 (20) 11/29 (38) 2.45 (1.03–5.81) 0.0424
animals in compound 95/116 (82) 24/29 (83) 1.00 (0.36–2.83) 0.9957
Water availability (not always per day) 60/116 (52) 7/29 (24) 0.31 (0.13–0.77) 0.0113 0.32 (0.12–0.81) 0.0167
access to improved water 95/116 (82) 25/29 (86) 1.28 (0.42–3.86) 0.6661
give stored water to child 109/115 (95) 27/29 (93) 0.65 (0.14–2.98) 0.5819
Treating water habit 5/116 (4) 3/29 (10) 2.68 (0.66–10.92) 0.1696
Facility to dispose child’s stool 110/116 (95) 28/29 (97) 1.12 (0.18–6.92) 0.9048
Improved facility for household stool 13/116 (11) 4/29 (14) 1.35 (0.43–4.28) 0.6069
Wash hands before eating 106/116 (91) 27/29 (93) 1.08 (0.26–4.58) 0.9122
Wash hands before cooking 70/116 (60) 19/29 (66) 1.22 (0.53–2.83) 0.6346
Wash hands before preparing baby’s food 34/116 (29) 3/29 (10) 0.32 (0.10–1.03) 0.0563 0.28 (0.08–0.94) 0.0394
Wash hands after defecating 101/116 (87) 24/29 (83) 0.68 (0.23–1.98) 0.4796
Wash hands after handling animals 4/116 (3) 1/29 (3) 1.32 (0.20–8.74) 0.7763
Wash hands after cleaning child feces 23/116 (20) 6/29 (21) 1.10 (0.41–2.93) 0.8480
Partial or exclusive breastfeeding 18/100 (18) 4/20 (20) 1.22 (0.38–3.87) 0.7404
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Table 6 Risk factors for Shigella infection in controls by crude and adjusted analysis









>6 months of age 595/1046 (57) 1/1 (100) 2.27 (0.09–55.97) 0.6151
child sex (male) 629/1046 (60) 1/1 (100) 1.99 (0.08–48.96) 0.6738
child primary caretaker (mother) 1035/1046 (99) 1/1 (100) 0.03 (0.00–0.86) 0.0404 0.03 (0.00–0.87) 0.0408
caretaker formal education 313/1044 (30) 1/1 (100) 7.00 (0.28–172.30) 0.2338
animals in compound 897/1045 (86) 1/1 (100) 0.50 (0.02–12.24) 0.6684
Water availability (not always per day) 333/1046 (32) 0/1 (0) 0.71 (0.03–17.55) 0.8361
access to improved water 888/1046 (85) 0/1 (0) 0.06 (0.00–1.47) 0.0844
give stored water to child 829/1046 (79) 0/1 (0) 0.09 (0.00–2.15) 0.1360
Treating water habit 66/1046 (6) 0/1 (0) 4.91 (0.20–121.81) 0.3310
Facility to dispose child’s stool 656/1046 (63) 1/1 (100) 1.78 (0.07–43.91) 0.7231
Improved facility for household stool 79/1046 (8) 0/1 (0) 4.06 (0.16–100.39) 0.3924
Wash hands before eating 980/1046 (94) 1/1 (100) 0.20 (0.01–5.04) 0.3310
Wash hands before cooking 855/1046 (82) 0/1 (0) 0.07 (0.00–1.84) 0.1124
Wash hands before preparing baby’s food 627/1046 (60) 1/1 (100) 2.01 (0.08–49.35) 0.6702
Wash hands after defecating 765/1046 (73) 1/1 (100) 1.10 (0.04–27.16) 0.9521
Wash hands after handling animals 421/1046 (40) 0/1 (0) 0.49 (0.02–12.17) 0.6667
Wash hands after cleaning child feces 642/1046 (61) 1/1 (100) 1.89 (0.08–46.48) 0.6972
Partial or exclusive breastfeeding 1018/1039 (98) 1/1 (100) 0.06 (0.00–1.60) 0.0939
lowest quintile of wealth index 194/1045 (19) 0/1 (0) 1.46 (0.06–35.96) 0.8172
12–23 months
>18 months of age 200/627 (32) 0/2 (0) 0.43 (0.02–8.92) 0.5828
child sex (male) 373/627 (59) 2/2 (100) 3.41 (0.16–71.26) 0.4294
child primary caretaker (mother) 598/627 (95) 2/2 (100) 0.25 (0.01–5.25) 0.3695
caretaker formal education 172/625 (28) 1/2 (50) 2.63 (0.27–25.45) 0.4039
animals in compound 555/627 (89) 2/2 (100) 0.65 (0.03–13.73) 0.7836
Water availability (not always per day) 216/627 (34) 2/2 (100) 9.50 (0.45–198.84) 0.1467
access to improved water 521/627 (83) 1/2 (50) 0.20 (0.02–1.98) 0.1707
give stored water to child 583/625 (93) 2/2 (100) 0.36 (0.02–7.71) 0.5166
Treating water habit 26/627 (4) 0/2 (0) 4.54 (0.21–96.93) 0.3327
Facility to dispose child’s stool 600/626 (96) 2/2 (100) 0.22 (0.01–4.71) 0.3333
Improved facility for household stool 27/627 (4) 0/2 (0) 4.37 (0.20–93.17) 0.3451
Wash hands before eating 596/627 (95) 1/2 (50) 0.05 (0.01–0.52) 0.0119 0.05 (0.01–0.52) 0.0119
Wash hands before cooking 522/627 (83) 2/2 (100) 1.01 (0.05–21.18) 0.9951
Wash hands before preparing baby’s food 386/627 (62) 0/2 (0) 0.12 (0.01–2.61) 0.1801
Wash hands after defecating 454/627 (72) 2/2 (100) 1.91 (0.09–39.96) 0.6770
Wash hands after handling animals 254/627 (41) 0/2 (0) 0.29 (0.01–6.14) 0.4294
Wash hands after cleaning child feces 367/627 (59) 0/2 (0) 0.14 (0.01–2.97) 0.2079
Partial or exclusive breastfeeding 443/621 (71) 2/2 (100) 2.01 (0.10–42.13) 0.6522
lowest quintile of wealth index 135/627 (22) 1/2 (50) 3.63 (0.38–35.22) 0.2654
24–59 months
>42 months of age 51/302 (17) 0/1 (0) 1.63 (0.07–40.52) 0.7664
child sex (male) 201/302 (67) 0/1 (0) 0.17 (0.01–4.16) 0.2759
child primary caretaker (mother) 268/302 (89) 1/1 (100) 0.39 (0.02–9.65) 0.5618
caretaker formal education 74/302 (25) 0/1 (0) 1.02 (0.04–25.37) 0.9892
animals in compound 252/302 (83) 1/1 (100) 0.60 (0.02–14.94) 0.7555
Water availability (not always per day) 103/302 (34) 0/1 (0) 0.64 (0.03–15.91) 0.7870
access to improved water 254/302 (84) 1/1 (100) 0.57 (0.02–14.24) 0.7332
give stored water to child 277/302 (92) 1/1 (100) 0.28 (0.01–6.94) 0.4337
Treating water habit 9/302 (3) 0/1 (0) 10.30 (0.39–269.66) 0.1616
Facility to dispose child’s stool 298/301 (99) 1/1 (100) 0.04 (0.00–1.02) 0.0515
Improved facility for household stool 24/302 (8) 0/1 (0) 3.79 (0.15–95.51) 0.4185
Wash hands before eating 286/302 (95) 1/1 (100) 0.17 (0.01–4.41) 0.2880
Wash hands before cooking 232/302 (77) 1/1 (100) 0.91 (0.04–22.58) 0.9539
Wash hands before preparing baby’s food 156/302 (52) 0/1 (0) 0.31 (0.01–7.72) 0.4768
Wash hands after defecating 210/302 (70) 0/1 (0) 0.15 (0.01–3.63) 0.2408
Wash hands after handling animals 122/302 (40) 1/1 (100) 4.42 (0.18–109.40) 0.3640
Wash hands after cleaning child feces 161/302 (53) 1/1 (100) 2.63 (0.11–65.04) 0.5550
Partial or exclusive breastfeeding 8/279 (3) 0/1 (0) 10.65 (0.40–280.87) 0.1566
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we found a low risk of Shigella-associated diarrhea in infancy 
and a steady increase through the second year of life. One 
likely explanation is that the partial or exclusive breastfeed-
ing, which was present in 97% of infants (<12 months) of age 
and in 61% of children under 2 years in our study, neutralized 
the infectious inoculum and prevented disease. The strong 
association between MSD caused by Shigella and children 
over 2 years of age has been attributed to a decreased expo-
sure to breast milk and an increased exposure to sources of 
Shigella infection such as hands contact in the environment 
as children become more active.29,30 In addition, the benefits 
of human milk for infant health have been recognized as an 
important source of bacteria that may contribute to neonatal 
gastrointestinal colonization leading to immune response 
development and possible infection prevention. Thus, the 
microbiota of breast-fed infants is considered the gold stan-
dard in terms of a healthy infant gastrointestinal microbiota.31
In addition, as children wean, they are exposed to 
an increased array of food and water that could serve as 
sources of Shigella, thus increasing the probability of getting 
infected.32 Therefore, this study also sought to quantify the 
effects of several socioeconomic indicators on the relative 
increased risk for acquiring Shigella in children present-
ing MSD. Overall, the role of the assessed risk factors for 
Shigella-MSD was age-related, possibly due to differences 
in the degree of exposure of the studied population. The 
presence of broader protective factors for diarrhea caused 
by Shigella in the present study could be attributed to an 
improved health-seeking behavior among the cases and 
improvement in accessibility of health services over the 
years. The population leaving in Manhiça district is under 
monitoring through HDSS since 1996, and is thus exposed 
Table 7 Impact of antibiotic treatment for Shigella-diarrhea in children outcome when leaving the hospital from December 2007 to 
november 2012
Outcomes Antibiotic treatment, n (%)
No Yes Total P-value
Improved 10/27 (37) 17/27 (63) 27 <0.0001
not improved 41/46 (89.1) 5/46 (10.8) 46
Total 51/73 (69.8) 22/73 (30.1) 73
Antibiotics administered Proportion, n (%) Resistance, n (%)
Trimethoprim-sulfametoxazole 7/73 (9.6) 62/67 (92.5)
gentamicin 9/73 (12.3) 0
chloramphenicol 6/73 (8.2) 36/67 (53.7)
amoxicillin clavulanic acid 4/73 (5.5) 3/67 (4.5)
ampicillin 9/73 (12.3) 34/67 (50.7)
nalidixic acid 5/73 (6.9) 0
Ciprofloxacin 1/73 (1.4) 0
to several interventions that contribute to health education 
that may influence the health-seeking behavior. This may 
explain why socioeconomic characteristics such as formal 
education were less relevant in the present study. Considering 
these variations, the importance of children primary caretaker 
(mother), giving stored water to child, water availability (not 
always per day), and washing hands before preparing baby’s 
food in preventing diarrhea caused by Shigella is highlighted.
The importance of hand-washing practices in preventing 
diarrheal illness is supported by a number of studies.33,34 A 
systematic review of several studies estimated that appropri-
ate hand washing with soap could reduce the risks of severe 
intestinal infections and shigellosis up to 48% and 59%, 
respectively.34 The fact that stored water consumption was 
protective for Shigella infection leads us to believe that the 
hygienic conditions for water transportation and the contain-
ers where the water is stored are adequate or properly cleaned, 
because water contamination can occur at any stage from the 
source to the point of use. Conversely, unavailability of water 
throughout the day was protective for Shigella infection and 
may reflect the rational use of scarce water at the household 
level, or be linked to the hypothesis that the lack of water 
can interrupt the chain of transmission of some waterborne 
transmitted enteropathogens like Shigella as families are less 
exposed due to the limited amount of water that they have. 
The prevalence of malnutrition in both Shigella-associated 
MSD and in non-Shigella MSD highlights the vicious cycle of 
malnutrition and diarrhea. While malnutrition makes children 
more vulnerable to diarrheal infections due to its negative 
effect on the barrier protection leading to deterioration of 
the immune system, chronic infections can contribute to 
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Conclusion
Shigella is a significant pathogen associated with MSD in 
Mozambican children from 1 to 5 years. The presence of 
cases of LSD caused by Shigella is a matter of concern and 
may suggest the need to expand the clinical feature of the 
disease. The presence of dysentery remains an important 
clinical feature of Shigella-associated diarrhea. The study 
reinforces the recommendations from the WHO on the use of 
antibiotic treatment for the management of shigellosis while 
vaccines to prevent disease are not available. As demon-
strated in this study, promoting awareness of good personal 
hygiene and a safe water storage is of great importance in 
prevention and control of the disease. Moreover, continuous 
surveillance studies are needed to track changes over time.
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